HER2-positive
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
10
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer
17
Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
11
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up.
12
Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells
2
Predictive and prognostic role of peripheral blood eosinophil count in triple negative and hormone receptor negative/HER2 positive breast cancers patients undergoing neoadjuvant treatment.
1
Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment
15
What do we learn from HER2-positive breast cancer genomic profiles?
7
Anti-HER2 vaccines: new prospects for breast cancer therapy.
44
The Dilemma of HER2 Double-equivocal Breast Carcinomas
11
Le profil hormonal, Her2 et prolifratif des carcinomes mammaires infiltrants, avec approche de classification molculaire
146
Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice
8
[Anti-EGFR and anti-HER2 monoclonal antibodies against pancreatic carcinomas]
5
Isolation and characterization of camelid single-domain antibodies against HER2
6
Le CpG et le poly(I:C) agissent en synergie avec le trastuzumab contre le cancer du sein HER2+
97
Traitement néoadjuvant du cancer du sein HER2-positif : à propos de l'étude EORTC LAPATAX
151
Non positive SVM
16
Une théorie positive de l'information et des choix
46
Positive multistate protein design
12
Discrimination positive et mobilité scolaire
153